C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2001
11/15/2001	CA2403264A1 Chiral fluoroquinolizinone arginine salt forms
11/14/2001	EP1153920A1 Quinoline derivatives and quinazoline derivatives
11/14/2001	EP0815087B1 Trisubstituted phenyl derivatives
11/13/2001	US6316658 Quinolone carboxylate chemical intermediates; microbiocides, bactericides
11/13/2001	US6316618 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives
11/13/2001	US6316617 For treating physiological disorders associated with an excess of neuropeptide y, such as feeding disorders and certain cardiovascular diseases, medical diagnosis
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001	US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001	US6316450 Compounds
11/08/2001	WO2001083438A2 New gamma selective retinoids
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001	US20010039348 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
11/08/2001	US20010039343 Pesticides, fungicides, herbicides, insecticides, microbiocdes, drugs
11/08/2001	US20010039287 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/08/2001	DE10019755A1 New cyclic carboxylic acids are integrin antagonists, useful for treating inflammatory diseases, autoimmune and immune disorders, e.g. atherosclerosis, asthma and diabetes
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407189A1 New gamma selective retinoids
11/07/2001	EP1150977A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
11/07/2001	EP1150973A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	CN1321154A Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001	US6313173 Glyoxylic acid amides
11/06/2001	US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/06/2001	US6313141 2-aminoalkylaminoquinolines as dopamine D4 ligands
11/06/2001	US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole
11/01/2001	WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001	WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes
11/01/2001	US20010036958 Antiinflammatory agents, antiasthmatics
11/01/2001	US20010036950 Potassium channel openers
11/01/2001	US20010036936 Compositions and methods for treating osteoporosis
11/01/2001	CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
10/2001
10/31/2001	EP1149080A2 Crystalline form of benzoquinoline-3-one derivative as inhibitor of 5-alpha reductase
10/31/2001	EP0929543B1 Herbicidal composition
10/31/2001	EP0787131B1 Benzenesulphonamide derivatives as bradykinine antagonists
10/31/2001	EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001	EP0719258B1 Cyclic amide derivatives for protecting against ultraviolet rays
10/31/2001	DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001	CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001	CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001	CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001	CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/30/2001	US6310246 Fluorovinloxyacetamides, process for preparing same and herbicidal composition comprising same
10/30/2001	US6310211 8-hydroxy-7-substituted quinolines as anti-viral agents
10/30/2001	US6310209 Synthesis of CC-1065/duocarmycin analogs
10/30/2001	US6310144 Blending rubbers with diene rubber with 0.5 to 5 parts by weight of a 2,2,4-trimethyl-1,2-dihydroquinoline polymer having a primary amine
10/30/2001	US6310107 (+)-6-(4-biphenylyl)methoxy-2-(2-(n,n-dimethylamino)ethyl)tetr alin, or a salt is useful for inhibiting production and/or secretion of amyloid-beta protein
10/30/2001	US6310075 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
10/25/2001	WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001	WO2001079161A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDE DERIVATIVES
10/25/2001	WO2001079159A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDES
10/25/2001	WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	WO2001078697A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001	WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001	US20010034448 New compounds, their preparation and use
10/25/2001	US20010034364 Isoprenoid pathway inhibitors for stimulating bone growth
10/25/2001	US20010034351 A quinazoline compound
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	CA2405233A1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001	CA2404263A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amide derivatives
10/25/2001	CA2403563A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amides
10/24/2001	EP1147094A1 Non-peptide glp-1 agonists
10/24/2001	EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents
10/24/2001	EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001	EP1146873A1 Anti-androgens and methods for treating disease
10/24/2001	CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001	CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001	CN1073553C Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines
10/24/2001	CN1073535C Method for preparing nanometre material by solid phase chemical reaction
10/23/2001	US6307050 Method of synthesizing flosequinan from 4-fluoroanthranilic acid
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6306950 Improving the heat resistance of the title resin by including titanium dioxide having a zinc content of <0.1%; also includes an impact modifier, a stabilizer and a lubricant; pipes for conveying hot water; extrusion; discoloration inhibition
10/23/2001	US6306911 Enzyme inhibitors
10/23/2001	US6306877 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
10/23/2001	US6306873 Substituted β-thiocarboxylic acids
10/23/2001	US6306840 Cell adhesion inhibitors
10/18/2001	WO2001077650A1 Analyte detection & apparatus therefor
10/18/2001	WO2001077105A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
10/18/2001	WO2001076629A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001	US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001	US20010031766 Prostaglandin receptor ligands
10/18/2001	CA2405163A1 Soluble beta amyloid precursor protein secretion promoters
10/17/2001	EP1144543A1 Electroluminescent quinolates
10/17/2001	EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001	EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143923A1 Agent and method for colouring fibres
10/17/2001	EP0554434B1 Imaging of infections
10/17/2001	CN1318058A 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as CRTP inhibitors
10/17/2001	CN1318057A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoliines as CETP inhibitors
10/17/2001	CN1073112C Possibly substituted 8-cyano-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
10/17/2001	CN1073102C New 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications

1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 277